The Aspirin Primary Prevention Conundrum

In this review, the authors re-examine the role of aspirin in the primary prevention of cardiovascular disease. They discuss the history of the use of aspirin in primary prevention, the current guidelines, and the recent evidence surrounding aspirin use as primary prevention in special populations s...

Full description

Saved in:
Bibliographic Details
Published inThe Israel Medical Association journal Vol. 22; no. 1; pp. 60 - 63
Main Authors Schamroth Pravda, Miri, Schamroth Pravda, Nili, Beigel, Yitzhak, Matetzky, Shlomi, Beigel, Roy
Format Journal Article
LanguageEnglish
Published Israel 01.01.2020
Subjects
Aspirin - adverse effects
Aspirin - therapeutic use
Cardiovascular Diseases - prevention & control
Fibrinolytic Agents - adverse effects
Fibrinolytic Agents - therapeutic use
Humans
Practice Guidelines as Topic
Primary Prevention - methods
Online AccessGet full text

Cover

More Information
Summary:In this review, the authors re-examine the role of aspirin in the primary prevention of cardiovascular disease. They discuss the history of the use of aspirin in primary prevention, the current guidelines, and the recent evidence surrounding aspirin use as primary prevention in special populations such as those with moderate cardiovascular risk, diabetes mellitus, and the elderly.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:1565-1088